We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Molecular Diagnostics

Image: Histopathology of advanced gastric carcinoma of the intestinal type shows gland-forming adenocarcinoma and adjacent intestinal metaplasia (Photo courtesy of Drs. Shabnam Bashir and Sudip Raina).

Biomarker Helps Predict Stomach Cancer Survival

A biomarker has been identified in patients with stomach cancer that starves tumors of their blood supply and reduces the ability of cancer cells to spread to other parts of the body.   More...
16 Sep 2015
Image: Histopathology of hilar cholangiocarcinoma or Klatskin tumor (Photo courtesy of the Nephron).

Independent Prognostic Biomarker Found for Klatskin Tumor Patients

Curative treatment of intrahepatic cholangiocarcinoma and hilar cholangiocarcinoma is limited to surgical resection or orthotopic liver transplantation, however, not all patients benefit from a surgical approach and suffer from early tumor recurrence.  More...
16 Sep 2015
Image: The \"Japonica Array\" contains 659,253 SNPs, including tag SNPs for imputation, SNPs of Y chromosome and mitochondria, and SNPs related to previously reported genome-wide association studies and pharmacogenomics (Photo courtesy of Tohoku Medical Megabank Organization).

Custom-Designed SNP Array Facilitates Japanese Genomic Studies

Japanese genomic researchers have created a single nucleotide polymorphism array optimized for studies on the Japanese population.  More...
16 Sep 2015
Image: Bone marrow aspirate smear showing blasts with high nuclear: cytoplasmic ratio from a patient with acute myeloid leukemia (Photo courtesy of the Cleveland Clinic).

Relapse In Leukemia Linked to Genetic Mutations

For patients with an often-deadly form of leukemia, lingering cancer-related mutations detected after initial treatment with chemotherapy, are associated with an increased risk of relapse and poor survival.  More...
14 Sep 2015
Image

Blood Test Developed to Catch Pancreatic Cancer Early

Pancreatic cancer is the fourth most common cause of cancer-related death in the USA and has a five-year survival rate of only 6%, which is the lowest rate of all types of cancer and this low survival rate is partially attributed to the difficulty in detecting pancreatic cancer at an early stage.   More...
08 Sep 2015

Liquid Biopsy Assay Predicts Risk of Breast Cancer Relapse

A liquid biopsy method for tracking mutations in circulating breast cancer cells enables physicians to predict cancer recurrence as early as eight months before physical symptoms appear.   More...
06 Sep 2015
Image: Gram stain of Streptococcus agalactiae or group B streptococcus (Photo courtesy of Institut Pasteur).

Mutated Group B Streptococcus Causes Neonatal Sepsis

Streptococcus agalactiae or group B Streptococcus is a commensal of the human gut and genitourinary tract, and a leading cause of neonatal infections, in which vertical transmission from mother to child remains the most frequent route of contamination.  More...
01 Sep 2015
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Manual Pipetting Aid
Pipette Controllers macro
New
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
INTEGRA BIOSCIENCES AG